文献速递糖尿病肥胖与代谢综合征

2型糖尿病中精氨酸、瓜氨酸和谷氨酰胺代谢受损:稳定同位素研究

Impaired arginine, citrulline, and glutamine metabolism in type 2 diabetes: insights from a stable isotope study.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

研究采用稳定同位素示踪方法,纳入21例2型糖尿病患者和21例对照者,评估精氨酸、瓜氨酸和谷氨酰胺的全身生成速率及动力学。结果显示2型糖尿病组血浆精氨酸、瓜氨酸和谷氨酰胺浓度均降低,瓜氨酸全身生成速率降低而谷氨酰胺和谷氨酸升高,提示精氨酸-瓜氨酸-谷氨酰胺代谢轴失调可能参与2型糖尿病代谢紊乱。

要点

  • 2型糖尿病患者血浆精氨酸、瓜氨酸和谷氨酰胺浓度均低于对照组。
  • 2型糖尿病中瓜氨酸全身生成速率降低,谷氨酰胺和谷氨酸升高。
  • 靶向谷氨酰胺驱动的糖异生并增加瓜氨酸可利用性可能有益。

核心结论

  • 2型糖尿病存在显著的Arg-Cit-Gln代谢失调。
  • 模型提示谷氨酰胺周转增加刺激糖异生、增加谷氨酰胺消耗并减少瓜氨酸用于Arg和NO合成。

研究设计与样本

  • 研究纳入42人(21例T2D,21例对照),过夜空腹后给予稳定氨基酸示踪剂脉冲,采集血样。
  • 采用LC-MS/MS测量血浆浓度和同位素富集度,进行隔室分析计算全身生成速率和动力学。

主要发现

  • 调整性别和年龄后,T2D组血浆Arg(P = .007)、Cit(P = .002)和Gln(P = .002)浓度低于对照组。
  • 控制年龄、性别和瘦软组织质量后,T2D组Cit全身生成速率较低(P = .004),Gln(P = .037)和谷氨酸(P = .017)较高。
  • T2D组Cit细胞内生成较低,Gln清除率和细胞内池大小较高,Arg清除率有升高趋势。

关键数值与推荐

  • 队列59.5%为女性,平均年龄64.4(7.5)岁,BMI 33.0(4.3)kg/m2,组间P > .05。

临床怎么用

  • 针对谷氨酰胺驱动的糖异生并增加瓜氨酸可利用性的干预可能有益于T2D管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Arginine (Arg) is an important amino acid in T2D as a potent insulin secretagogue and precursor for nitric oxide (NO). Citrulline (Cit), the substrate for de novo Arg synthesis, is mostly produced from glutamine (Gln). OBJECTIVE: We aimed to investigate their metabolism in T2D using a novel stable isotope tracer approach. METHODS: We studied 42 individuals (21 with T2D, 21 controls). After overnight fasting, blood samples were collected following pulse administration of stable amino acid tracers. Plasma concentrations and isotopic enrichments were measured by LC-MS/MS, and compartmental analyses were performed to calculate their whole-body production (WBP) rates and kinetics. RESULTS: The cohort was 59.5% female, with a mean age of 64.4 (7.5) years and a BMI of 33.0 (4.3) kg/m2 (all P > .05). After adjusting for sex and age, the T2D group had lower plasma concentrations of Arg (P = .007), Cit (P = .002), and Gln (P = .002) than the control group. In T2D, WBP was lower for Cit (P = .004) but higher for Gln (P = .037) and glutamate (P = .017) after controlling for age, sex, and lean soft tissue mass. The T2D group also had lower Cit intracellular production, but higher Gln clearance and intracellular pool size, and a trend toward higher Arg clearance. CONCLUSION: Significant dysregulation exists in Arg-Cit-Gln metabolism in T2D. Our findings suggest a working model in which increased Gln turnover stimulates gluconeogenesis, increases Gln consumption, and reduces Cit availability for Arg and NO synthesis, thereby contributing to metabolic dysregulation in T2D. Interventions targeting Gln-driven gluconeogenesis while increasing Cit availability may benefit T2D management.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Tosur M, Wierzchowska-McNew RA, Deutz NEP, et al. Impaired arginine, citrulline, and glutamine metabolism in type 2 diabetes: insights from a stable isotope study. J Clin Endocrinol Metab. 2026. PMID: 41655235. doi:10.1210/clinem/dgag055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。